Yes. Very good reason to be: Regen BioPharma Inc. Submits Response to FDA Questions on HemaXellerate Investigational New Drug Application http://www.prnewswire.com/news-releases/regen-biopharma-inc-submits-response-to-fda-questions-on-hemaxellerate-investigational-new-drug-application-550996231.html $BMSN/RGBP